Corsair Phama

Developer of drugs for the treatemnt of cardiac diseases

placeSan Francisco, California, United States calendar_todayFounded 2014 groups5 employees language corsairpharma.com

Social engagement

Social engagement: 512 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include New Rhein.

Investor typeCountShare
Venture capital120%
Private equity360%
Angel & family office120%

Recent activity

22 Jun 2026
Event
PHA 2026
8 Jun 2026
Event
2026 Pulmonary Hypertension Association (PHA) Conference
22 Sep 2025
Event
2025 Pulmonary Hypertension Professional Network (PHPN) Symposium
Coming soon